Stage III Pancreatic Cancer

specific

Stage III includes: (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4, Any N, M0). T1: Tumor measuring 2 cm or less in greatest dimension. T2: Tumor measuring more than 2 cm and 4 cm or less in greatest dimension. T3: Tumor measuring more than 4 cm in greatest dimension. T4: Tumor involving the celiac axis, superior mesenteric artery, and/or common hepatic artery, regardless of size. N2: Metastasis in four or more regional lymph nodes. M0: No distant metastasis. (AJCC 8th ed.)

40

Centers

10

Active Trials

Cancer Funding

Top Centers for Stage III Pancreatic Cancer(40)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
High-Volume Research Center
73.2
2
NCI Clinical
High-Volume Research Center
72.1
3
NCI Comprehensive
Active Research Program
68.7
4
NCI Comprehensive
Active Research Program
68.7
5
NCI Comprehensive
Active Research Program
68.7
6
NCI Comprehensive
Active Research Program
68.7
7
NCI Comprehensive
Active Research Program
68.7
8
NCI Comprehensive
47.3
9
NCI Comprehensive
47.3
10
NCI Comprehensive
47.3
1147.3
1247.3
13
NCI Comprehensive
47.3
14
NCI Comprehensive
47.3
1547.3
16
NCI Comprehensive
47.3
1747.3
1847.3
1947.3
20
NCI Comprehensive
47.3
21
NCI Comprehensive
47.3
22
NCI Comprehensive
47.3
23
NCI Comprehensive
47.3
24
NCI Comprehensive
47.3
25
NCI Comprehensive
47.3
26
NCI Comprehensive
47.3
2747.3
2847.3
2947.3
30
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
47.3
3147.3
32
NCI Comprehensive
47.3
3347.3
3447.3
3547.3
3647.3
3747.3
3847.3
3947.3
4047.3

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →